Press Release: SCHILLER Americas Earns Technology Breakthrough Designation with Premier, Inc.

05.06.24 05:21 PM Comment(s) By Joel


Resistant hypertension
CONTACT: Michael Schulz,, +1 (417) 527 - 0396


SCHILLER Americas awarded Pulmonary Function and Metabolic Analyzers agreement and Technology Breakthrough Designation with Premier, Inc. 

Doral, Florida – 5/28/2024 – SCHILLER Americas has been awarded a national group purchasing agreement and Technology Breakthrough Designation for Pulmonary Function and Metabolic Analyzers with Premier, Inc. Effective 5/1/2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for tremoflo®.

Premier offers Breakthrough Technology designations to innovations that offer a major advantage in terms of patient safety, clinical outcomes, and operational efficiencies.

“SCHILLER is very excited to offer this oscillometric breakthrough technology to help improve the healthcare of the Premier membership patients” – Francesco Iacona, CEO.

tremoflo® is an innovative device employing airway oscillometry to monitor lung function and diagnose conditions such as asthma and COPD. Suitable for patients of all age groups, including adults, geriatrics, and pediatric individuals, the device requires only normal breathing through its mouthpiece for operation. Oscillometry, the underlying technology, assesses lung function by measuring respiratory system resistance and reactance through wave analysis. Built on the Forced Oscillation Technique (FOT), tremoflo® superimposes multifrequency airwaves onto the patient's tidal breathing to evaluate lung function accurately.

Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,350 U.S. hospitals and 300,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, consulting, and other services, Premier enables better care and outcomes at a lower cost.

For over four decades, SCHILLER Americas has been a leading provider of high-quality and accurate cardiopulmonary technology in the US, supporting physicians in making informed medical decisions. Their products, developed and manufactured using cutting-edge technology in Switzerland, France, Canada, and the US, adhere to the latest international standards. In today's healthcare landscape, where electronic health records are paramount, SCHILLER's offerings facilitate seamless information exchange among health systems, leveraging LAN and Wi-Fi connectivity and ensuring interoperability through HL7, DICOM, or PDF standards. Committed to enhancing patient care across various healthcare settings, SCHILLER's dedicated team ensures comprehensive support for healthcare providers. 


Share -